로딩 중…
지수 로딩 중…
MannKind Corporation
MNKD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.94+0.51%
2026-06-18
Price Chart
MannKind Corporation+3.41%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.22B |
| Revenue | $361M |
| Net Income | $-24M |
| Total Assets | $744M |
| Net Assets | $-59M |
| Value | |
| P/S | 3.37x |
| EV/EBITDA | 56.18x |
| FCF Yield | 1.04% |
| Profitability | |
| ROA | -3.21% |
| Op. Margin | 3.71% |
| Revenue Growth | 15.08% |
| Earnings Growth | -226.30% |
| Financial Health | |
| Total Debt | $437M |
| FCF | $13M |
| Cash | $53M |
| Current Ratio | 1.87x |
| Net Debt/EBITDA | 13.47x |
| Performance | |
| 1Y Return | 3.41% |
| 1M Return | 33.11% |
| From 52W High | -39.48% |
| 1Y MDD | -63.28% |
| Trading | |
| Volume | 11,621,796 shares |
| Trading Value | $46M |
| Per Share | |
| EPS | $0.02 |